title: p90 ribosomal S6 kinase regulates activity of the renin-angiotensin system: a pathogenic mechanism for ischemia-reperfusion injury.
abstract: Increasing evidence suggests that local renin-angiotensin system (RAS) plays an important role in cardiac diseases. Elevated p90 ribosomal S6 kinase (RSK) activity has been observed in diabetic animal, as well as in human failing hearts. We hypothesize that RSK mediates cardiac dysfunction by up regulating local RAS signaling. In the present study, we show that the prorenin mRNA level was significantly increased (~5.6-fold) in transgenic mouse hearts with cardiac specific expression of RSK (RSK-Tg). The RSK-Tg mice were more vulnerable to ischemia/reperfusion (I/R) injury than non-transgenic littermate controls (NLC). To further understand the direct contribution of cardiac renin to I/R injury, we used a Langendorff system to evaluate the effect of renin inhibition by aliskiren in RSK-Tg mouse hearts. In the vehicle-perfused group, I/R significantly decreased left ventricular developed pressure (LVDP) in RSK-Tg hearts compared to NLC (7% versus 60% of the baseline). However, aliskiren perfusion significantly increased LVDP in RSK-Tg (7% to 61%, p<0.01) but not in NLC hearts (60% to 62%, n.s.). The protective effect of aliskiren in RSK-Tg hearts was further demonstrated with positive (contraction) dp/dt (6.5% to 63%, p<0.01) and rate pressure product (RPP) (5% to 51%, p<0.01). Moreover, aliskiren significantly decreased I/R induced infarction in RSK-Tg (60% to 32%, p<0.01), compared to NLC hearts (37% to 32%, n.s.). These results suggest that RSK plays a crucial role in regulating local cardiac renin, which contributes to I/R induced cardiac injury and dysfunction. Thus, renin inhibition may provide an alternative therapeutic strategy under conditions of increased RAS.
authors: Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14620, USA.
authors: Xi
authors: X
authors: Shi
authors: Chen
authors: C
authors: Yan
authors: Sergiy M
authors: SM
authors: Nadtochiy
authors: Jun-Ichi
authors: J
authors: Abe
authors: Paul S
authors: PS
authors: Brookes
authors: Bradford C
authors: BC
authors: Berk
references: Cardiovasc Res. 2002 Jan;53(1):131-7
references: 11744021
references: Hypertension. 2008 Dec;52(6):1068-75
references: 18955663
references: Eur J Heart Fail. 2011 Jan;13(1):107-14
references: 21169387
references: Circ Heart Fail. 2008 May;1(1):17-24
references: 19808266
references: Circulation. 2008 Aug 12;118(7):773-84
references: 18695203
references: Nephrol Dial Transplant. 2009 May;24(5):1663-71
references: 19145003
references: N Engl J Med. 2008 Jun 5;358(23):2433-46
references: 18525041
references: Heart Vessels. 1995;10(6):285-93
references: 8655465
references: Eur J Heart Fail. 2011 Jan;13(1):100-6
references: 21123186
references: Circulation. 2006 May 30;113(21):2516-23
references: 16717153
references: Circulation. 2009 Feb 3;119(4):530-7
references: 19153265
references: Circulation. 1998 Jul 7;98(1):73-81
references: 9665063
references: Circulation. 2006 Apr 11;113(14):1787-98
references: 16585392
references: Br J Pharmacol. 1998 Feb;123(3):405-12
references: 9504380